NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US64051A1016
NEONC TECHNOLOGIES HOLDINGS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 39,990.00 USD |
| Operating income | -58.24 m USD |
| EBIT | -59.64 m USD |
| Net income | -62.15 m USD |
| Diluted EPS – continuing operations | -3.20 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
More stocks
- STRATUS PROPERTIES INC (STRS)
- ISC Fresh Water Investment SOCIMI SA (YISC.MC)
- Daesung Energy (117580.KS)
- Answer Technology Co Ltd (3528.TW)
- Commercial Vehicle Group, Inc. (CVGI)
- Paxman AB (PAX.ST)
- SPEAR Investments I BV (QEV.AS)
- Asia Tech Image (4974.TWO)
- Pang Rim Spinn (003610.KS)
- Curiosis (494120.KQ)
- Sungei Bagan Rubber Malaya (2569.KL)
- Capital B SA (ALCPB.PA)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.